首页 > 最新文献

Journal of Pathology and Translational Medicine最新文献

英文 中文
The proteomic landscape shows oncologic relevance in cystitis glandularis. 蛋白质组学图显示腺性膀胱炎的肿瘤学相关性。
IF 2.4 Q3 PATHOLOGY Pub Date : 2023-01-01 DOI: 10.4132/jptm.2022.10.24
Jun Yong Kim, Dohyun Han, Hyeyoon Kim, Minsun Jung, Han Suk Ryu

Background: The relationship between cystitis glandularis (CG) and bladder malignancy remains unclear.

Methods: We identified the oncologic significance of CG at the molecular level using liquid chromatography-tandem mass spectrometry-based proteomic analysis of 10 CG, 12 urothelial carcinoma (UC), and nine normal urothelium (NU) specimens. Differentially expressed proteins (DEPs) were identified based on an analysis of variance false discovery rate < 0.05, and their functional enrichment was analyzed using a network model, Gene Set Enrichment Analysis, and Gene Ontology annotation.

Results: We identified 9,890 proteins across all samples and 1,139 DEPs among the three entities. A substantial number of DEPs overlapped in CG/NU, distinct from UC. Interestingly, we found that a subset of DEP clusters (n = 53, 5%) was differentially expressed in NU but similarly between CG and UC. This "UC-like signature" was enriched for reactive oxygen species (ROS) and energy metabolism, growth and DNA repair, transport, motility, epithelial-mesenchymal transition, and cell survival. Using the top 10 shortlisted DEPs, including SOD2, PRKCD, CYCS, and HCLS1, we identified functional elements related to ROS metabolism, development, and transport using network analysis. The abundance of these four molecules in UC/CG than in NU was consistent with the oncologic functions in CG.

Conclusions: Using a proteomic approach, we identified a predominantly non-neoplastic landscape of CG, which was closer to NU than to UC. We also confirmed a small subset of common DEPs in UC and CG, suggesting that altered ROS metabolism might imply potential cancerous risks in CG.

背景:腺性膀胱炎(CG)与膀胱恶性肿瘤的关系尚不清楚。方法:采用液相色谱-串联质谱技术对10例CG、12例尿路上皮癌(UC)和9例正常尿路上皮(NU)标本进行蛋白质组学分析,在分子水平上确定CG的肿瘤学意义。基于方差分析(false discovery rate < 0.05)对差异表达蛋白(differential expression protein, DEPs)进行识别,并利用网络模型、基因集富集分析(Gene Set enrichment analysis)和基因本体注释(Gene Ontology annotation)对其功能富集进行分析。结果:我们在所有样品中鉴定出9890种蛋白质,在三个实体中鉴定出1139种dep。与UC不同,在CG/NU中有大量dep重叠。有趣的是,我们发现DEP簇的一个子集(n = 53,5%)在NU中表达差异,但在CG和UC中表达相似。这种“uc样特征”丰富于活性氧(ROS)和能量代谢、生长和DNA修复、运输、运动、上皮-间质转化和细胞存活。利用前10名入围的DEPs,包括SOD2、PRKCD、CYCS和HCLS1,我们通过网络分析确定了与ROS代谢、发育和运输相关的功能元件。这四种分子在UC/CG中的丰度高于NU,这与CG的肿瘤功能一致。结论:使用蛋白质组学方法,我们确定了CG的主要非肿瘤性景观,其更接近NU而不是UC。我们还证实了UC和CG中有一小部分常见的dep,这表明ROS代谢的改变可能意味着CG中存在潜在的癌症风险。
{"title":"The proteomic landscape shows oncologic relevance in cystitis glandularis.","authors":"Jun Yong Kim,&nbsp;Dohyun Han,&nbsp;Hyeyoon Kim,&nbsp;Minsun Jung,&nbsp;Han Suk Ryu","doi":"10.4132/jptm.2022.10.24","DOIUrl":"https://doi.org/10.4132/jptm.2022.10.24","url":null,"abstract":"<p><strong>Background: </strong>The relationship between cystitis glandularis (CG) and bladder malignancy remains unclear.</p><p><strong>Methods: </strong>We identified the oncologic significance of CG at the molecular level using liquid chromatography-tandem mass spectrometry-based proteomic analysis of 10 CG, 12 urothelial carcinoma (UC), and nine normal urothelium (NU) specimens. Differentially expressed proteins (DEPs) were identified based on an analysis of variance false discovery rate < 0.05, and their functional enrichment was analyzed using a network model, Gene Set Enrichment Analysis, and Gene Ontology annotation.</p><p><strong>Results: </strong>We identified 9,890 proteins across all samples and 1,139 DEPs among the three entities. A substantial number of DEPs overlapped in CG/NU, distinct from UC. Interestingly, we found that a subset of DEP clusters (n = 53, 5%) was differentially expressed in NU but similarly between CG and UC. This \"UC-like signature\" was enriched for reactive oxygen species (ROS) and energy metabolism, growth and DNA repair, transport, motility, epithelial-mesenchymal transition, and cell survival. Using the top 10 shortlisted DEPs, including SOD2, PRKCD, CYCS, and HCLS1, we identified functional elements related to ROS metabolism, development, and transport using network analysis. The abundance of these four molecules in UC/CG than in NU was consistent with the oncologic functions in CG.</p><p><strong>Conclusions: </strong>Using a proteomic approach, we identified a predominantly non-neoplastic landscape of CG, which was closer to NU than to UC. We also confirmed a small subset of common DEPs in UC and CG, suggesting that altered ROS metabolism might imply potential cancerous risks in CG.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"57 1","pages":"67-74"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/3a/jptm-2022-10-24.PMC9846008.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10590532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metallic implant-associated lymphoma: ALK-negative anaplastic large cell lymphoma associated with total knee replacement arthroplasty. 金属假体相关淋巴瘤:与全膝关节置换术相关的alk阴性间变性大细胞淋巴瘤。
IF 2.4 Q3 PATHOLOGY Pub Date : 2023-01-01 DOI: 10.4132/jptm.2022.10.30
Jai-Hyang Go

Metallic implant-associated lymphomas are extremely rare. Only seven cases have been reported in association with knee joint arthroplasty, and all tumors were large B-cell lymphomas. This report is the first case of anaplastic large cell lymphoma occurring after total knee replacement arthroplasty. An 80‑year‑old female patient was admitted because of right knee pain for 2 years. She had undergone total knee replacement arthroplasty 10 years prior. Computed tomography showed an irregular osteolytic lesion in the right lateral femoral condyle, adjacent to the metallic prosthesis. Histologic findings reveal sheets of anaplastic tumor cells that were positive for CD2, CD4, CD5, CD43, and CD30 but negative for CD3, CD20, CD15, and anaplastic lymphoma kinase. Epstein-Barr encoding region in situ hybridization was negative. Analysis of T-cell receptor γ gene rearrangement studies using BIOMED-2-based multiplex polymerase chain reaction confirmed monoclonal T cell proliferation. The woman was finally diagnosed with ALK-negative anaplastic large cell lymphoma.

金属植入物相关淋巴瘤极为罕见。仅报道了7例与膝关节置换术相关的病例,所有肿瘤均为大b细胞淋巴瘤。本报告为第一例全膝关节置换术后发生间变性大细胞淋巴瘤。一例80岁女性患者因右膝疼痛2年入院。她在10年前接受了全膝关节置换术。计算机断层扫描显示在金属假体附近的右外侧股骨髁有不规则的溶骨性病变。组织学结果显示间变性肿瘤细胞片CD2、CD4、CD5、CD43和CD30阳性,但CD3、CD20、CD15和间变性淋巴瘤激酶阴性。Epstein-Barr编码区原位杂交阴性。利用基于biomed -2的多重聚合酶链反应分析T细胞受体γ基因重排研究,证实单克隆T细胞增殖。这名妇女最终被诊断为alk阴性间变性大细胞淋巴瘤。
{"title":"Metallic implant-associated lymphoma: ALK-negative anaplastic large cell lymphoma associated with total knee replacement arthroplasty.","authors":"Jai-Hyang Go","doi":"10.4132/jptm.2022.10.30","DOIUrl":"https://doi.org/10.4132/jptm.2022.10.30","url":null,"abstract":"<p><p>Metallic implant-associated lymphomas are extremely rare. Only seven cases have been reported in association with knee joint arthroplasty, and all tumors were large B-cell lymphomas. This report is the first case of anaplastic large cell lymphoma occurring after total knee replacement arthroplasty. An 80‑year‑old female patient was admitted because of right knee pain for 2 years. She had undergone total knee replacement arthroplasty 10 years prior. Computed tomography showed an irregular osteolytic lesion in the right lateral femoral condyle, adjacent to the metallic prosthesis. Histologic findings reveal sheets of anaplastic tumor cells that were positive for CD2, CD4, CD5, CD43, and CD30 but negative for CD3, CD20, CD15, and anaplastic lymphoma kinase. Epstein-Barr encoding region in situ hybridization was negative. Analysis of T-cell receptor γ gene rearrangement studies using BIOMED-2-based multiplex polymerase chain reaction confirmed monoclonal T cell proliferation. The woman was finally diagnosed with ALK-negative anaplastic large cell lymphoma.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"57 1","pages":"75-78"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2d/f9/jptm-2022-10-30.PMC9846009.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10596567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Infections and immunity: associations with obesity and related metabolic disorders. 感染和免疫:与肥胖和相关代谢紊乱的关系。
IF 2.4 Q3 PATHOLOGY Pub Date : 2023-01-01 DOI: 10.4132/jptm.2022.11.14
Amitabha Ray, Melissa J L Bonorden, Rajashree Pandit, Katai J Nkhata, Anupam Bishayee

About one-fourth of the global population is either overweight or obese, both of which increase the risk of insulin resistance, cardiovascular diseases, and infections. In obesity, both immune cells and adipocytes produce an excess of pro-inflammatory cytokines that may play a significant role in disease progression. In the recent coronavirus disease 2019 (COVID-19) pandemic, important pathological characteristics such as involvement of the renin-angiotensin-aldosterone system, endothelial injury, and pro-inflammatory cytokine release have been shown to be connected with obesity and associated sequelae such as insulin resistance/type 2 diabetes and hypertension. This pathological connection may explain the severity of COVID-19 in patients with metabolic disorders. Many studies have also reported an association between type 2 diabetes and persistent viral infections. Similarly, diabetes favors the growth of various microorganisms including protozoal pathogens as well as opportunistic bacteria and fungi. Furthermore, diabetes is a risk factor for a number of prion-like diseases. There is also an interesting relationship between helminths and type 2 diabetes; helminthiasis may reduce the pro-inflammatory state, but is also associated with type 2 diabetes or even neoplastic processes. Several studies have also documented altered circulating levels of neutrophils, lymphocytes, and monocytes in obesity, which likely modifies vaccine effectiveness. Timely monitoring of inflammatory markers (e.g., C-reactive protein) and energy homeostasis markers (e.g., leptin) could be helpful in preventing many obesity-related diseases.

全球约有四分之一的人口超重或肥胖,这两种情况都增加了胰岛素抵抗、心血管疾病和感染的风险。在肥胖中,免疫细胞和脂肪细胞都会产生过量的促炎细胞因子,这可能在疾病进展中起重要作用。在最近的2019冠状病毒病(COVID-19)大流行中,重要的病理特征,如肾素-血管紧张素-醛固酮系统的参与、内皮损伤和促炎细胞因子释放,已被证明与肥胖及其相关的后遗症(如胰岛素抵抗/ 2型糖尿病和高血压)有关。这种病理联系可以解释COVID-19在代谢紊乱患者中的严重程度。许多研究也报道了2型糖尿病和持续性病毒感染之间的联系。同样,糖尿病有利于各种微生物的生长,包括原生动物病原体以及机会性细菌和真菌。此外,糖尿病是许多朊病毒样疾病的危险因素。蠕虫和2型糖尿病之间还有一个有趣的关系;蠕虫病可能会降低促炎状态,但也与2型糖尿病甚至肿瘤进程有关。几项研究也记录了肥胖患者的中性粒细胞、淋巴细胞和单核细胞循环水平的改变,这可能会改变疫苗的有效性。及时监测炎症标志物(如c反应蛋白)和能量稳态标志物(如瘦素)可能有助于预防许多与肥胖相关的疾病。
{"title":"Infections and immunity: associations with obesity and related metabolic disorders.","authors":"Amitabha Ray,&nbsp;Melissa J L Bonorden,&nbsp;Rajashree Pandit,&nbsp;Katai J Nkhata,&nbsp;Anupam Bishayee","doi":"10.4132/jptm.2022.11.14","DOIUrl":"https://doi.org/10.4132/jptm.2022.11.14","url":null,"abstract":"<p><p>About one-fourth of the global population is either overweight or obese, both of which increase the risk of insulin resistance, cardiovascular diseases, and infections. In obesity, both immune cells and adipocytes produce an excess of pro-inflammatory cytokines that may play a significant role in disease progression. In the recent coronavirus disease 2019 (COVID-19) pandemic, important pathological characteristics such as involvement of the renin-angiotensin-aldosterone system, endothelial injury, and pro-inflammatory cytokine release have been shown to be connected with obesity and associated sequelae such as insulin resistance/type 2 diabetes and hypertension. This pathological connection may explain the severity of COVID-19 in patients with metabolic disorders. Many studies have also reported an association between type 2 diabetes and persistent viral infections. Similarly, diabetes favors the growth of various microorganisms including protozoal pathogens as well as opportunistic bacteria and fungi. Furthermore, diabetes is a risk factor for a number of prion-like diseases. There is also an interesting relationship between helminths and type 2 diabetes; helminthiasis may reduce the pro-inflammatory state, but is also associated with type 2 diabetes or even neoplastic processes. Several studies have also documented altered circulating levels of neutrophils, lymphocytes, and monocytes in obesity, which likely modifies vaccine effectiveness. Timely monitoring of inflammatory markers (e.g., C-reactive protein) and energy homeostasis markers (e.g., leptin) could be helpful in preventing many obesity-related diseases.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"57 1","pages":"28-42"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ed/7c/jptm-2022-11-14.PMC9846011.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10596596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
What's new in neuromuscular pathology 2022: myopathy updates and gene therapies. 2022年神经肌肉病理学最新进展:肌病更新和基因治疗。
IF 2.4 Q3 PATHOLOGY Pub Date : 2023-01-01 DOI: 10.4132/jptm.2022.10.14
Chunyu Cai

This compilation of new changes in the diagnosis and treatment of muscle and nerve disease is extracted from the latest publications from the European Neuromuscular Centre International workshops, FDA.gov and clinicaltrials.gov.

这份关于肌肉和神经疾病诊断和治疗新变化的汇编摘自欧洲神经肌肉中心国际研讨会、FDA.gov和clinicaltrials.gov的最新出版物。
{"title":"What's new in neuromuscular pathology 2022: myopathy updates and gene therapies.","authors":"Chunyu Cai","doi":"10.4132/jptm.2022.10.14","DOIUrl":"https://doi.org/10.4132/jptm.2022.10.14","url":null,"abstract":"<p><p>This compilation of new changes in the diagnosis and treatment of muscle and nerve disease is extracted from the latest publications from the European Neuromuscular Centre International workshops, FDA.gov and clinicaltrials.gov.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"57 1","pages":"79-80"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/86/c6/jptm-2022-10-14.PMC9846006.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9156382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-cell and spatial sequencing application in pathology. 单细胞和空间测序在病理学中的应用。
IF 1.7 Q3 PATHOLOGY Pub Date : 2023-01-01 Epub Date: 2023-01-10 DOI: 10.4132/jptm.2022.12.12
Yoon-Seob Kim, Jinyong Choi, Sug Hyung Lee

Traditionally, diagnostic pathology uses histology representing structural alterations in a disease's cells and tissues. In many cases, however, it is supplemented by other morphology-based methods such as immunohistochemistry and fluorescent in situ hybridization. Single-cell RNA sequencing (scRNA-seq) is one of the strategies that may help tackle the heterogeneous cells in a disease, but it does not usually provide histologic information. Spatial sequencing is designed to assign cell types, subtypes, or states according to the mRNA expression on a histological section by RNA sequencing. It can provide mRNA expressions not only of diseased cells, such as cancer cells but also of stromal cells, such as immune cells, fibroblasts, and vascular cells. In this review, we studied current methods of spatial transcriptome sequencing based on their technical backgrounds, tissue preparation, and analytic procedures. With the pathology examples, useful recommendations for pathologists who are just getting started to use spatial sequencing analysis in research are provided here. In addition, leveraging spatial sequencing by integration with scRNA-seq is reviewed. With the advantages of simultaneous histologic and single-cell information, spatial sequencing may give a molecular basis for pathological diagnosis, improve our understanding of diseases, and have potential clinical applications in prognostics and diagnostic pathology.

传统上,病理诊断使用组织学方法来描述疾病细胞和组织的结构变化。但在许多情况下,组织学还需要辅以其他基于形态学的方法,如免疫组化和荧光原位杂交。单细胞 RNA 测序(scRNA-seq)是有助于解决疾病中异质性细胞问题的策略之一,但它通常不能提供组织学信息。空间测序的目的是通过 RNA 测序,根据组织切片上的 mRNA 表达来确定细胞类型、亚型或状态。它不仅能提供病变细胞(如癌细胞)的 mRNA 表达,还能提供基质细胞(如免疫细胞、成纤维细胞和血管细胞)的 mRNA 表达。在这篇综述中,我们根据技术背景、组织制备和分析程序研究了目前的空间转录组测序方法。通过病理学实例,我们为刚刚开始在研究中使用空间测序分析的病理学家提供了有用的建议。此外,还对空间测序与 scRNA-seq 的整合进行了综述。空间测序具有同时获得组织学和单细胞信息的优势,可为病理诊断提供分子基础,提高我们对疾病的认识,并在预后和病理诊断方面具有潜在的临床应用价值。
{"title":"Single-cell and spatial sequencing application in pathology.","authors":"Yoon-Seob Kim, Jinyong Choi, Sug Hyung Lee","doi":"10.4132/jptm.2022.12.12","DOIUrl":"10.4132/jptm.2022.12.12","url":null,"abstract":"<p><p>Traditionally, diagnostic pathology uses histology representing structural alterations in a disease's cells and tissues. In many cases, however, it is supplemented by other morphology-based methods such as immunohistochemistry and fluorescent in situ hybridization. Single-cell RNA sequencing (scRNA-seq) is one of the strategies that may help tackle the heterogeneous cells in a disease, but it does not usually provide histologic information. Spatial sequencing is designed to assign cell types, subtypes, or states according to the mRNA expression on a histological section by RNA sequencing. It can provide mRNA expressions not only of diseased cells, such as cancer cells but also of stromal cells, such as immune cells, fibroblasts, and vascular cells. In this review, we studied current methods of spatial transcriptome sequencing based on their technical backgrounds, tissue preparation, and analytic procedures. With the pathology examples, useful recommendations for pathologists who are just getting started to use spatial sequencing analysis in research are provided here. In addition, leveraging spatial sequencing by integration with scRNA-seq is reviewed. With the advantages of simultaneous histologic and single-cell information, spatial sequencing may give a molecular basis for pathological diagnosis, improve our understanding of diseases, and have potential clinical applications in prognostics and diagnostic pathology.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"57 1","pages":"43-51"},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bc/ca/jptm-2022-12-12.PMC9846004.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10588845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinicopathologic and immunohistochemical study of primary and secondary breast angiosarcoma 原发性和继发性乳腺血管肉瘤的临床病理和免疫组织化学研究
IF 2.4 Q3 PATHOLOGY Pub Date : 2022-10-26 DOI: 10.4132/jptm.2022.08.31
E. Abada, H. Jang, Seong-Min Kim, R. Ali-Fehmi, S. Bandyopadhyay
Background We aimed to study the clinicopathologic and immunohistochemical (IHC) (CD117, c-Myc, and p53) characteristics, and overall survival of primary and secondary breast angiosarcoma (BAS). Methods This was a retrospective study of BAS cases diagnosed between 1997 and 2020 at our institution. Hematoxylin and eosin-stained slides were reviewed for tumor morphology, margin status, and lymph node metastasis. CD117, p53, D2-40, CD31, and c-Myc IHC stains were performed on 11 viable tissue blocks. Additional clinical information was obtained from the electronic medical records. Results Seventeen patients with BAS were identified. Of these, five (29%) were primary and 12 (71%) were secondary BAS, respectively. The median age at diagnosis for primary BAS was 36 years. The median age at diagnosis for secondary BAS was 67 years. The median time to secondary BAS development following radiotherapy was 6.5 years (range, 2 to 12 years). There was no significant difference between primary and secondary BAS in several histopathologic parameters examined, including histologic grade, necrosis, mitotic count, lymph node metastasis, and positive tumor margins. There was also no difference in CD117, p53, D2-40, CD31, and c-Myc expression by IHC between primary and secondary BAS. During a median followup of 21 months, primary BAS had two (40%) reported deaths and secondary BAS had three (25%) reported deaths. However, this difference in survival between both groups was not statistically significant (hazard ratio, 0.51; 95% confidence interval, 0.09 to 3.28; p = .450). Conclusions BAS is a rare and aggressive disease. No histologic, IHC (CD117, c-Myc, and p53), or survival differences were identified between primary and secondary BAS in this study.
背景我们旨在研究原发性和继发性乳腺血管肉瘤(BAS)的临床病理和免疫组织化学(IHC)(CD117、c-Myc和p53)特征以及总生存率。方法对我院1997年至2020年间诊断的BAS病例进行回顾性研究。对苏木精和伊红染色的载玻片的肿瘤形态、边缘状态和淋巴结转移进行了回顾。对11个活组织块进行CD117、p53、D2-40、CD31和c-Myc IHC染色。从电子病历中获得了其他临床信息。结果发现BAS患者17例。其中,5例(29%)为原发性BAS,12例(71%)为继发性BAS。诊断为原发性BAS的中位年龄为36岁。诊断为继发性BAS的中位年龄为67岁。放疗后继发BAS发展的中位时间为6.5年(范围为2至12年)。原发性和继发性BAS在检查的几个组织病理学参数方面没有显著差异,包括组织学分级、坏死、有丝分裂计数、淋巴结转移和阳性肿瘤边缘。原发性BAS和继发性BAS的IHC表达CD117、p53、D2-40、CD31和c-Myc也没有差异。在21个月的中位随访中,原发性BAS有两例(40%)报告死亡,继发性BAS有三例(25%)报告死亡。然而,两组之间的生存率差异没有统计学意义(危险比为0.51;95%置信区间为0.09至3.28;p=.450)。结论BAS是一种罕见的侵袭性疾病。在本研究中,原发性和继发性BAS之间没有发现组织学、IHC(CD117、c-Myc和p53)或生存差异。
{"title":"A clinicopathologic and immunohistochemical study of primary and secondary breast angiosarcoma","authors":"E. Abada, H. Jang, Seong-Min Kim, R. Ali-Fehmi, S. Bandyopadhyay","doi":"10.4132/jptm.2022.08.31","DOIUrl":"https://doi.org/10.4132/jptm.2022.08.31","url":null,"abstract":"Background We aimed to study the clinicopathologic and immunohistochemical (IHC) (CD117, c-Myc, and p53) characteristics, and overall survival of primary and secondary breast angiosarcoma (BAS). Methods This was a retrospective study of BAS cases diagnosed between 1997 and 2020 at our institution. Hematoxylin and eosin-stained slides were reviewed for tumor morphology, margin status, and lymph node metastasis. CD117, p53, D2-40, CD31, and c-Myc IHC stains were performed on 11 viable tissue blocks. Additional clinical information was obtained from the electronic medical records. Results Seventeen patients with BAS were identified. Of these, five (29%) were primary and 12 (71%) were secondary BAS, respectively. The median age at diagnosis for primary BAS was 36 years. The median age at diagnosis for secondary BAS was 67 years. The median time to secondary BAS development following radiotherapy was 6.5 years (range, 2 to 12 years). There was no significant difference between primary and secondary BAS in several histopathologic parameters examined, including histologic grade, necrosis, mitotic count, lymph node metastasis, and positive tumor margins. There was also no difference in CD117, p53, D2-40, CD31, and c-Myc expression by IHC between primary and secondary BAS. During a median followup of 21 months, primary BAS had two (40%) reported deaths and secondary BAS had three (25%) reported deaths. However, this difference in survival between both groups was not statistically significant (hazard ratio, 0.51; 95% confidence interval, 0.09 to 3.28; p = .450). Conclusions BAS is a rare and aggressive disease. No histologic, IHC (CD117, c-Myc, and p53), or survival differences were identified between primary and secondary BAS in this study.","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"56 1","pages":"342 - 353"},"PeriodicalIF":2.4,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42677402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice 韩国细胞病理学实践现状:冠状病毒大流行对细胞病理学的影响
IF 2.4 Q3 PATHOLOGY Pub Date : 2022-10-26 DOI: 10.4132/jptm.2022.09.21
Soon Auck Hong, H. Jung, S. S. Kim, Min-Sun Jin, J. Pyo, J. Jeong, Younghee Choi, G. Gong, Y. Chong
Background The Continuous Quality Improvement program for cytopathology in 2020 was completed during the coronavirus pandemic. In this study, we report the result of the quality improvement program. Methods Data related to cytopathology practice from each institute were collected and processed at the web-based portal. The proficiency test was conducted using glass slides and whole-slide images (WSIs). Evaluation of the adequacy of gynecology (GYN) slides from each institution and submission of case glass slides and WSIs for the next quality improvement program were performed. Results A total of 214 institutions participated in the annual cytopathology survey in 2020. The number of entire cytopathology specimens was 8,220,650, a reduction of 19.0% from the 10,111,755 specimens evaluated in 2019. Notably, the number of respiratory cytopathology specimens, including sputum and bronchial washing/ brushing significantly decreased by 86.9% from 2019, which could be attributed to the global pandemic of coronavirus disease. The ratio of cases with atypical squamous cells to squamous intraepithelial lesions was 4.10. All participating institutions passed the proficiency test and the evaluation of adequacy of GYN slides. Conclusions Through the Continuous Quality Improvement program, the effect of coronavirus disease 2019 pandemic, manifesting with a reduction in the number of cytologic examinations, especially in respiratory-related specimen has been identified. The Continuous Quality Improvement Program of the Korean Society for Cytopathology can serve as the gold standard to evaluate the current status of cytopathology practice in Korea.
背景2020年细胞病理学持续质量改进计划是在冠状病毒大流行期间完成的。在这项研究中,我们报告了质量改进计划的结果。方法在网络门户网站上收集和处理各研究所的细胞病理学实践相关数据。使用玻璃载玻片和全载玻片图像(WSI)进行能力测试。对每个机构的妇科(GYN)载玻片的充分性进行评估,并为下一个质量改进计划提交病例玻璃载玻片和WSI。结果共有214家机构参加了2020年的年度细胞病理学调查。整个细胞病理学标本的数量为8220650个,比2019年评估的10111755个标本减少了19.0%。值得注意的是,包括痰液和支气管冲洗/刷牙在内的呼吸道细胞病理学标本数量比2019年显著减少了86.9%,这可能归因于冠状病毒疾病的全球大流行。非典型鳞状细胞与鳞状上皮内病变的病例比例为4.10。所有参与机构都通过了能力测试和妇科幻灯片的充分性评估。结论通过持续质量改进计划,已经确定了2019冠状病毒病大流行的影响,表现为细胞学检查次数的减少,特别是在呼吸道相关标本中。韩国细胞病理学会的持续质量改进计划可以作为评估韩国细胞病理学实践现状的金标准。
{"title":"Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice","authors":"Soon Auck Hong, H. Jung, S. S. Kim, Min-Sun Jin, J. Pyo, J. Jeong, Younghee Choi, G. Gong, Y. Chong","doi":"10.4132/jptm.2022.09.21","DOIUrl":"https://doi.org/10.4132/jptm.2022.09.21","url":null,"abstract":"Background The Continuous Quality Improvement program for cytopathology in 2020 was completed during the coronavirus pandemic. In this study, we report the result of the quality improvement program. Methods Data related to cytopathology practice from each institute were collected and processed at the web-based portal. The proficiency test was conducted using glass slides and whole-slide images (WSIs). Evaluation of the adequacy of gynecology (GYN) slides from each institution and submission of case glass slides and WSIs for the next quality improvement program were performed. Results A total of 214 institutions participated in the annual cytopathology survey in 2020. The number of entire cytopathology specimens was 8,220,650, a reduction of 19.0% from the 10,111,755 specimens evaluated in 2019. Notably, the number of respiratory cytopathology specimens, including sputum and bronchial washing/ brushing significantly decreased by 86.9% from 2019, which could be attributed to the global pandemic of coronavirus disease. The ratio of cases with atypical squamous cells to squamous intraepithelial lesions was 4.10. All participating institutions passed the proficiency test and the evaluation of adequacy of GYN slides. Conclusions Through the Continuous Quality Improvement program, the effect of coronavirus disease 2019 pandemic, manifesting with a reduction in the number of cytologic examinations, especially in respiratory-related specimen has been identified. The Continuous Quality Improvement Program of the Korean Society for Cytopathology can serve as the gold standard to evaluate the current status of cytopathology practice in Korea.","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"56 1","pages":"361 - 369"},"PeriodicalIF":2.4,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48053889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea BRAF VE1免疫组织化学在非小细胞肺癌中的作用:韩国15名病理学家的多机构研究
IF 2.4 Q3 PATHOLOGY Pub Date : 2022-10-26 DOI: 10.4132/jptm.2022.08.22
S. Chang, Yoon-La Choi, H. Shim, G. Lee, S. Ha
Background Next-generation sequencing (NGS) is an approved test to select patients for BRAF V600E targeted therapy in Korea. However, the high cost, long turnaround times, and the need for sophisticated equipment and skilled personnel limit the use of NGS in daily practice. Immunohistochemistry (IHC) is a rapid and relatively inexpensive assay available in most laboratories. Therefore, in this study, we evaluate the usefulness of BRAF VE1 IHC in terms of predictive value and interobserver agreement in non–small cell lung cancers (NSCLCs). Methods A total of 30 cases with known BRAF mutation status were selected, including 20 cases of lung adenocarcinomas, six cases of colorectal adenocarcinomas, and four cases of papillary thyroid carcinomas. IHC for BRAF V600E was carried out using the VE1 antibody. Fifteen pathologists independently scored both the staining intensity and the percentage of tumor cell staining on whole slide images. Results In the lung adenocarcinoma subset, interobserver agreement for the percentage of tumor cell staining and staining intensity was good (percentage of tumor cell staining, intraclass correlation coefficient = 0.869; staining intensity, kappa = 0.849). The interobserver agreement for the interpretation using the cutoff of 40% was almost perfect in the entire study group and the lung adenocarcinoma subset (kappa = 0.815). Sensitivity, specificity, positive predictive value, and negative predictive value of BRAF VE1 IHC were 80.0%, 90.0%, 88.9%, and 81.8%, respectively. Conclusions BRAF VE1 IHC could be a screening test for the detection of BRAF V600E mutation in NSCLC. However, further studies are needed to optimize the protocol and to establish and validate interpretation criteria for BRAF VE1 IHC.
在韩国,下一代测序(NGS)是选择BRAF V600E靶向治疗患者的一种被批准的检测方法。然而,高成本、长周转时间以及对精密设备和熟练人员的需求限制了NGS在日常实践中的使用。免疫组织化学(IHC)是一种快速且相对便宜的检测方法,大多数实验室都可以使用。因此,在本研究中,我们评估了BRAF VE1 IHC在非小细胞肺癌(nsclc)中的预测价值和观察者间一致性的有用性。方法选取已知BRAF突变状态的30例患者,其中肺腺癌20例,结直肠腺癌6例,甲状腺乳头状癌4例。采用VE1抗体对BRAF V600E进行免疫组化检测。15名病理学家独立对整个切片图像的染色强度和肿瘤细胞染色百分比进行评分。结果在肺腺癌亚群中,肿瘤细胞染色百分比和染色强度的观察者间一致性较好(肿瘤细胞染色百分比,类内相关系数= 0.869;染色强度,kappa = 0.849)。在整个研究组和肺腺癌亚组中,使用40%截断值解释的观察者间一致性几乎是完美的(kappa = 0.815)。BRAF VE1 IHC的敏感性为80.0%,特异性为90.0%,阳性预测值为88.9%,阴性预测值为81.8%。结论BRAF V600E基因IHC可作为非小细胞肺癌BRAF V600E基因突变的筛查方法。然而,需要进一步的研究来优化方案,并建立和验证BRAF VE1 IHC的解释标准。
{"title":"Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea","authors":"S. Chang, Yoon-La Choi, H. Shim, G. Lee, S. Ha","doi":"10.4132/jptm.2022.08.22","DOIUrl":"https://doi.org/10.4132/jptm.2022.08.22","url":null,"abstract":"Background Next-generation sequencing (NGS) is an approved test to select patients for BRAF V600E targeted therapy in Korea. However, the high cost, long turnaround times, and the need for sophisticated equipment and skilled personnel limit the use of NGS in daily practice. Immunohistochemistry (IHC) is a rapid and relatively inexpensive assay available in most laboratories. Therefore, in this study, we evaluate the usefulness of BRAF VE1 IHC in terms of predictive value and interobserver agreement in non–small cell lung cancers (NSCLCs). Methods A total of 30 cases with known BRAF mutation status were selected, including 20 cases of lung adenocarcinomas, six cases of colorectal adenocarcinomas, and four cases of papillary thyroid carcinomas. IHC for BRAF V600E was carried out using the VE1 antibody. Fifteen pathologists independently scored both the staining intensity and the percentage of tumor cell staining on whole slide images. Results In the lung adenocarcinoma subset, interobserver agreement for the percentage of tumor cell staining and staining intensity was good (percentage of tumor cell staining, intraclass correlation coefficient = 0.869; staining intensity, kappa = 0.849). The interobserver agreement for the interpretation using the cutoff of 40% was almost perfect in the entire study group and the lung adenocarcinoma subset (kappa = 0.815). Sensitivity, specificity, positive predictive value, and negative predictive value of BRAF VE1 IHC were 80.0%, 90.0%, 88.9%, and 81.8%, respectively. Conclusions BRAF VE1 IHC could be a screening test for the detection of BRAF V600E mutation in NSCLC. However, further studies are needed to optimize the protocol and to establish and validate interpretation criteria for BRAF VE1 IHC.","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"56 1","pages":"334 - 341"},"PeriodicalIF":2.4,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48354443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Papillary and medullary thyroid carcinomas coexisting in the same lobe, first suspected based on fine-needle aspiration cytology: a case report. 甲状腺乳头状癌和髓样癌共存于同一叶,首次怀疑基于细针穿刺细胞学:1例报告。
IF 2.4 Q3 PATHOLOGY Pub Date : 2022-09-01 Epub Date: 2022-09-13 DOI: 10.4132/jptm.2022.08.03
Hyun Hee Koh, Young Lyun Oh

Because different types of thyroid malignancies have distinct embryological origins, coexisting tumors are rarely observed. We describe a coexisting papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC) first suspected by fine-needle aspiration cytology (FNAC). A 57-year-old female presented with an irregular mass in the right thyroid lobe. The cytopathologic findings of fine-needle aspiration showed two components: a papillary-like arrangement consisting of cells with pale enlarged nuclei indicative of PTC and loose clusters comprised of oval cells with granular chromatin indicative of MTC. The diagnosis of a coexisting PTC and MTC was initially confirmed by calcitonin immunocytochemistry and later after total thyroidectomy. Although some surgical case reports of PTC and MTC coexisting in either the same or different lobes have been documented, a case suspected by FNAC before the surgery has rarely been reported. Because appropriate treatment and prognosis of PTC and MTC are different, cytopathologists should be aware of this rare entity.

由于不同类型的甲状腺恶性肿瘤具有不同的胚胎起源,因此很少观察到共存的肿瘤。我们描述了一种共存的甲状腺乳头状癌(PTC)和甲状腺髓样癌(MTC),首次被细针穿刺细胞学(FNAC)怀疑。一位57岁的女性在右侧甲状腺叶出现不规则肿块。细针穿刺的细胞病理学结果显示两个组成部分:乳头状排列,由细胞核苍白增大的细胞组成,表明PTC;松散的簇状排列,由染色质颗粒状的椭圆形细胞组成,表明MTC。PTC和MTC共存的诊断最初通过降钙素免疫细胞化学证实,后来在甲状腺全切除术后确诊。虽然有一些手术病例报告PTC和MTC共存于同一或不同的叶,但在手术前怀疑有FNAC的病例很少报道。由于PTC和MTC的适当治疗和预后不同,细胞病理学家应该注意这种罕见的实体。
{"title":"Papillary and medullary thyroid carcinomas coexisting in the same lobe, first suspected based on fine-needle aspiration cytology: a case report.","authors":"Hyun Hee Koh,&nbsp;Young Lyun Oh","doi":"10.4132/jptm.2022.08.03","DOIUrl":"https://doi.org/10.4132/jptm.2022.08.03","url":null,"abstract":"<p><p>Because different types of thyroid malignancies have distinct embryological origins, coexisting tumors are rarely observed. We describe a coexisting papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC) first suspected by fine-needle aspiration cytology (FNAC). A 57-year-old female presented with an irregular mass in the right thyroid lobe. The cytopathologic findings of fine-needle aspiration showed two components: a papillary-like arrangement consisting of cells with pale enlarged nuclei indicative of PTC and loose clusters comprised of oval cells with granular chromatin indicative of MTC. The diagnosis of a coexisting PTC and MTC was initially confirmed by calcitonin immunocytochemistry and later after total thyroidectomy. Although some surgical case reports of PTC and MTC coexisting in either the same or different lobes have been documented, a case suspected by FNAC before the surgery has rarely been reported. Because appropriate treatment and prognosis of PTC and MTC are different, cytopathologists should be aware of this rare entity.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"56 5","pages":"301-308"},"PeriodicalIF":2.4,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/32/b2/jptm-2022-08-03.PMC9510044.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40372803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn's disease: image processing and analysis study. 炎症和组织重塑促进狭窄性克罗恩病的纤维生成:图像处理和分析研究。
IF 2.4 Q3 PATHOLOGY Pub Date : 2022-09-01 Epub Date: 2022-07-04 DOI: 10.4132/jptm.2022.05.18
Mustafa Erdem Arslan, Rupinder Brar, Lianna Goetz, Dipti Karamchandani, Michael W Mikula, Kyle Hodge, Hua Li, Sangtae Ahn, Hwajeong Lee

Background: Inflammation and structural remodeling may contribute to fibrogenesis in Crohn's disease (CD). We quantified the immunoexpression of calretinin, CD34, and calprotectin as a surrogate for mucosal innervation, telocytes (interstitial cells playing a role in networking), and inflammation, respectively, and correlated them with bowel alterations in stricturing CD.

Methods: Primary resection specimens for ileal CD (n = 44, 31 stricturing CD, 13 inflammatory CD) were identified. Left-sided ulcerative colitis and trauma cases were used as controls. Proximal and distal margin and middle (diseased) sections were stained for calretinin, CD34, and calprotectin. Microscopic images were captured from the mucosa (calretinin), submucosa (calprotectin), and myenteric plexus (CD34), and the immunostaining was quantified using image processing and analysis. Bowel thickness at the corresponding sections were measured and correlated with the amount of immunoexpression.

Results: A total of 2,037 images were analyzed. In stricturing CD, submucosal alteration/thickening at the stricture site correlated with calprotectin staining and inversely correlated with calretinin staining at the proximal margin. Muscularis propria alteration/thickening at the stricture site correlated with mucosal calretinin staining at the proximal margin. Submucosal alteration/thickening at the proximal margin correlated with calretinin and CD34 staining at the proximal margin and inversely correlated with CD34 staining at the stricture site. Calretinin immunostaining at the distal margin was significantly higher in stricturing CD than the controls.

Conclusions: Inflammation and tissue remodeling appear to contribute to fibrogenesis in stricturing CD. Increased mucosal calretinin immunostaining distal to the diseased segment could be helpful in diagnosing CD in the right clinical context.

背景:炎症和结构重塑可能有助于克罗恩病(CD)的纤维生成。我们分别量化了calretinin、CD34和calprotectin的免疫表达,作为粘膜神经分布、远端细胞(在网络中起作用的间质细胞)和炎症的替代指标,并将它们与狭窄性CD的肠道改变联系起来。方法:鉴定了44例回肠CD (n = 44, 31例狭窄性CD, 13例炎症性CD)的初步切除标本。左侧溃疡性结肠炎和创伤病例作为对照。近端、远端边缘和中间(病变)切片染色calretinin, CD34和calprotectin。显微图像采集粘膜(calretinin)、粘膜下层(calprotectin)和肌丛(myenteric plexus) (CD34),通过图像处理和分析定量免疫染色。测量相应切片的肠厚,并与免疫表达量相关。结果:共分析2037张图像。在狭窄性CD中,狭窄部位的粘膜下改变/增厚与钙保护蛋白染色相关,与近缘钙保护蛋白染色负相关。狭窄部位固有肌层改变/增厚与近缘粘膜calcalin染色相关。近缘粘膜下改变/增厚与近缘calretinin和CD34染色相关,与狭窄部位CD34染色呈负相关。狭窄性CD远端缘Calretinin免疫染色明显高于对照组。结论:炎症和组织重塑似乎有助于狭窄性乳糜泻的纤维生成。病变远端粘膜calretinin免疫染色增加可能有助于在正确的临床背景下诊断乳糜泻。
{"title":"Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn's disease: image processing and analysis study.","authors":"Mustafa Erdem Arslan,&nbsp;Rupinder Brar,&nbsp;Lianna Goetz,&nbsp;Dipti Karamchandani,&nbsp;Michael W Mikula,&nbsp;Kyle Hodge,&nbsp;Hua Li,&nbsp;Sangtae Ahn,&nbsp;Hwajeong Lee","doi":"10.4132/jptm.2022.05.18","DOIUrl":"https://doi.org/10.4132/jptm.2022.05.18","url":null,"abstract":"<p><strong>Background: </strong>Inflammation and structural remodeling may contribute to fibrogenesis in Crohn's disease (CD). We quantified the immunoexpression of calretinin, CD34, and calprotectin as a surrogate for mucosal innervation, telocytes (interstitial cells playing a role in networking), and inflammation, respectively, and correlated them with bowel alterations in stricturing CD.</p><p><strong>Methods: </strong>Primary resection specimens for ileal CD (n = 44, 31 stricturing CD, 13 inflammatory CD) were identified. Left-sided ulcerative colitis and trauma cases were used as controls. Proximal and distal margin and middle (diseased) sections were stained for calretinin, CD34, and calprotectin. Microscopic images were captured from the mucosa (calretinin), submucosa (calprotectin), and myenteric plexus (CD34), and the immunostaining was quantified using image processing and analysis. Bowel thickness at the corresponding sections were measured and correlated with the amount of immunoexpression.</p><p><strong>Results: </strong>A total of 2,037 images were analyzed. In stricturing CD, submucosal alteration/thickening at the stricture site correlated with calprotectin staining and inversely correlated with calretinin staining at the proximal margin. Muscularis propria alteration/thickening at the stricture site correlated with mucosal calretinin staining at the proximal margin. Submucosal alteration/thickening at the proximal margin correlated with calretinin and CD34 staining at the proximal margin and inversely correlated with CD34 staining at the stricture site. Calretinin immunostaining at the distal margin was significantly higher in stricturing CD than the controls.</p><p><strong>Conclusions: </strong>Inflammation and tissue remodeling appear to contribute to fibrogenesis in stricturing CD. Increased mucosal calretinin immunostaining distal to the diseased segment could be helpful in diagnosing CD in the right clinical context.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"56 5","pages":"239-248"},"PeriodicalIF":2.4,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ea/71/jptm-2022-05-18.PMC9510042.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40374270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Pathology and Translational Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1